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Background: The causal association of C-reactive protein (CRP) and fibrinogen on 
intracerebral hemorrhage (ICH) remains uncertain. We investigated the causal associations 
of CRP and fibrinogen with ICH using two-sample Mendelian randomization.
Method: We used single-nucleotide polymorphisms associated with CRP and fibrinogen 
as instrumental variables. The summary data on ICH were obtained from the International 
Stroke Genetics Consortium (1,545 cases and 1,481 controls). Two-sample Mendelian 
randomization estimates were performed to assess with inverse-variance weighted and 
sensitive analyses methods including the weighted median, the penalized weighted 
median, pleiotropy residual sum and outlier (MR-PRESSO) approaches. MR-Egger 
regression was used to explore the pleiotropy.
Results: The MR analyses indicated that genetically predicted CRP concentration was not 
associated with ICH, with an odds ratio (OR) of 1.263 (95% CI = 0.935–1.704, p = 0.127). 
Besides, genetically predicted fibrinogen concentration was not associated with an increased 
risk of ICH, with an OR of 0.879 (95% CI = 0.060–18.281; p = 0.933). No evidence of 
pleiotropic bias was detected by MR-Egger. The findings were overall robust in sensitivity analyses.
Conclusions: Our findings did not support that CRP and fibrinogen are causally associated 
with the risk of ICH.
Keywords: C-reactive protein, fibrinogen, single-nucleotide polymorphisms, Mendelian randomization, 
intracerebral hemorrhage
INTRODUCTION
Globally, stroke is a leading cause of death with a high societal burden in most regions 
(GBD 2015 Mortality and Causes of Death Collaborators, 2016). Among adults, the risk of 
stroke from the age of 25  years is approximately 25% (Feigin et  al., 2018). Hemorrhagic stroke 
(HS) as a subtype of stroke carries high morbidity and mortality rates (Stokum et  al., 2015), 
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and intracerebral hemorrhage (ICH) is by far the most common 
type of HS (Qureshi et  al., 2009). Inflammation plays an 
important part in pathogenesis of stroke by influencing 
the development of atherosclerosis and plaque instability 
(Barone and Feuerstein, 1999; Scirica and Morrow, 2006).
C-reactive protein (CRP) and fibrinogen, considered as well-
proven clinical markers of systemic inflammation, are acute-
phase protein synthesized by hepatocytes against inflammation 
(Dalmon et  al., 1993; Pepys and Hirschfield, 2003) and can 
increase the risk of cardiovascular disease (Scirica and Morrow, 
2006; Zhang et  al., 2014) and stroke (Coull et  al., 1991; Cao 
et  al., 2007; Jiménez et  al., 2015). Significantly increased levels 
of fibrinogen are commonly found in patients with stroke, 
suggesting that fibrinogen is elevated before thrombotic incidents 
occur and is a risk factor for stroke (Coull et  al., 1991). 
However, Roudbary et al. (2011) revealed that CRP concentration 
was not improved in patients with HS. No associations of 
CRP and fibrinogen with ICH were identified in a nested 
case-control study (Karim et  al., 2020). The observational 
epidemiologic studies on the associations of CRP and fibrinogen 
with ICH showed inconsistent results (Coull et  al., 1991; 
Roudbary et  al., 2011). Furthermore, potential unmeasured 
confounders and reverse causation bias in observational studies 
limit the ability to ascertain causal inferences.
Mendelian randomization (MR) is a genetic epidemiological 
method to explore the association between the exposure and 
outcome, using genetic variants as instrumental variables (IVs) 
for the exposure (Smith and Ebrahim, 2003). Because of the 
independent segregation and randomized assignment of alleles 
at meiosis, MR approach can control potential confounders 
and reverse causation, making stronger causal inference (Lawlor 
et  al., 2008). Therefore, we  conducted two-sample MR analysis 
to assess the causal relationships of CRP and fibrinogen in 
the development of ICH in European population.
MATERIALS AND METHODS
Study Design and Data Sources
A two-sample MR approach was used to investigate the causal 
effects of CRP and fibrinogen on the risk of ICH. The study 
design is under the assumption that the genetic variants are 
associated with CRP and fibrinogen, but not with confounders. 
Besides, the genetic variants affect risk of ICH only through 
exposure and not through any alternative pathways.
Information on genetic variants associated with level of CRP 
was collected from a meta-analysis of genome-wide association 
study (GWAS), which is currently the largest study attempted 
to identify genetic variants in relation to CRP concentration 
involving 204,402 individuals from 88 previous population-
based cohort studies (Ligthart et  al., 2018). In genetic variants 
associated with fibrinogen, we used previously published genetic 
variants of a GWAS meta-analysis involving more than 100,000 
subjects (Sabater-Lleal et  al., 2013).
Summary statistics data on associations of genetic variants 
with ICH were obtained from the published GWAS meta-
analysis by the International Stroke Genetics Consortium (ISGC) 
of 3,026 participants (1,545 cases and 1,481 controls; 
Woo et  al., 2014). All data in our MR analyses were restricted 
to individuals of European ancestry only.
Genetic Variants
We used single-nucleotide polymorphisms (SNPs) published 
previously, which reached genome-wide significance 
(p  <  5  ×  10−8) for CRP and fibrinogen concentrations as MR 
IVs. The selected SNPs were independent, namely, not in linkage 
disequilibrium (r2  <  0.2). Nineteen SNPs (11 for CRP and 8 
for fibrinogen) were not presented in ISGC datasets. For the 
unavailable SNPs in outcome datasets, we  replaced them with 
proxy SNPs. The proxy SNPs in linkage disequilibrium (r2 > 0.8) 
were identified for two SNPs. Accordingly, 42 SNPs for CRP 
and 16 SNPs for fibrinogen were included in the analysis of 
ICH. The summary genetic association data are reported in 
Supplementary Table S1.
Mendelian Randomization Analysis
We performed two-sample MR analyses to estimate the associations 
of CRP and fibrinogen with ICH using summarized data. Causal 
effects on ICH of CRP and fibrinogen concentrations were 
estimated using the conventional inverse-variance weighted (IVW) 
method (Burgess et  al., 2013). We  also conducted sensitivity 
analyses using the weighted median (WM), the penalized weighted 
median (PWM), and pleiotropy residual sum and outlier 
(MR-PRESSO) methods (Bowden et  al., 2015, 2016; Verbanck 
et  al., 2018). For MR-Egger regression analysis, we  assessed 
directional pleiotropy based on its intercepts (Burgess and 
Thompson, 2017). A leave-one-out analysis (omitted one SNP 
in turn) was performed to test the influence of outlying values 
(Burgess and Thompson, 2017). Heterogeneity of individual genetic 
variants was evaluated by Cochran’s Q test. All results are presented 
as an odds ratio (OR) with 95%  confidence interval (CI) of 
the outcomes per predicted increase in CRP and fibrinogen 
concentrations. The associations of each SNP with CRP and 
fibrinogen concentrations are further plotted compared to their 
effects for the outcomes. All analyses were performed by the 
TwoSampleMR and MR-PRESSO packages with R version 4.0.2.
RESULTS
Causal Association of CRP With ICH
The results of associations between genetically determined CRP 
and fibrinogen and the risk of ICH were presented in Table  1. 
Genetic predisposition to CRP levels were not observed to 
be  statistically significantly associated with ICH by performing 
IVW method (OR  =  1.263, 95% CI  =  0.935–1.704, p  =  0.127). 
The lack of causal association remained in all sensitivity analyses 
(all p  >  0.05; Table  1).
The MR-Egger method showed no evidence of directional 
pleiotropy for the association of CRP with ICH [odds (intercept), 
−0.010; p  =  0.480; Table  2]. For IVs, MR-PRESSO did not 
detect any potential outliers. Likewise, no heterogeneity was 
observed among individual SNPs of CRP for ICH (Q = 36.775, 
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p  =  0.616, Table  2). We  calculated the individual and pooled 
MR estimates between each CRP-related SNP and the risk for 
ICH shown as forest plots and scatter plots in Figure  1. The 
result of leave-one-out sensitivity analysis showed that the 
association between CRP and ICH was not substantially driven 
by any individual SNP (Supplementary Figure S1).
Causal Association of Fibrinogen With ICH
Regarding fibrinogen, we  found no causal effect of genetically 
instrumented fibrinogen on ICH (OR = 0.879, 95% CI = 0.042–
18.281, p  =  0.933). No significant association was observed 
for ICH in sensitivity analyses that were performed by WM, 
PWM, MR-PRESSO, and MR-Egger methods (Table  1).
The MR-Egger method showed no evidence of directional 
pleiotropy for the association of fibrinogen with ICH (Table 2). 
For IVs, MR-PRESSO did not detect any potential outliers. 
We calculated the individual and pooled MR estimates between 
each fibrinogen-related SNP and risk for ICH shown as forest 
plots and scatter plots in Figure  2. Furthermore, analysis on 
leaving out each SNP revealed that the inverse association 
between fibrinogen concentrations and ICH was not substantially 
driven by any individual SNP (Supplementary Figure S2). 
However, the Cochran Q statistic was 28.028 with an associated 
p  <  0.05, suggesting some heterogeneity in the effect estimates 
of fibrinogen and ICH (Table 2), but there was no clear evidence 
of directional pleiotropy (p for intercept  >  0.05, Table  2).
DISCUSSION
In the present study, we  assessed whether high circulating 
levels of CRP and fibrinogen are causally associated with ICH 
using two-sample MR analysis in European population. In the 
present study using publicly available summary statistics data, 
we  did not find CRP and fibrinogen levels might increase 
ICH risk. The findings were overall robust in sensitivity analyses.
Apart from being markers of systemic inflammation, CRP 
and fibrinogen are acute-phase protein induced by 
proinflammatory cytokine contributing to host defense against 
infection (Dalmon et  al., 1993; Pepys and Hirschfield, 2003). 
Previous studies investigated associations between CRP and 
fibrinogen and ICH but reported inconsistent results. A large-
scale cohort study found that CRP and fibrinogen were not 
associated with a significantly greater risk of HS (Jiménez et al., 
2016), while a retrospective cohort study suggested that increased 
CRP was a significant risk factor for in-hospital mortality 
among patients with cardiovascular disease including ICH 
(Yoshinaga et  al., 2017).
In our analysis, we  did not observe the relationships of CRP 
and fibrinogen with ICH. These findings suggested that the 
role of CRP and fibrinogen may be  less important in causing 
the risk of ICH. A previous MR study indicated that CRP 
concentration itself was unlikely to be  even a modest causal 
factor in coronary heart disease (Wensley et  al., 2011). Our 
findings corroborate earlier studies that showed CRP had no 
clear effect on ICH risk (Liu et  al., 2014). Similar results were 
also found in a meta-analysis consisting of six population-based 
prospective studies (Georgakis et al., 2019). Another meta-analysis 
has also suggested that elevated baseline CRP levels exhibited 
no clear effect on HS (Zhou et  al., 2016). However, evidence 
from a few prospective studies showed that CRP level in HS 
patients was significantly elevated (Das et al., 2014; Xue et al., 2017).
Fibrinogen participates in platelet aggregation, thrombogenic 
activity, atherogenesis, and inflammation, and the role of fibrinogen 
is probably various in the different subtypes of stroke. Our 
findings were supported by previous studies, which also reported 
TABLE 1 | Mendelian randomization (MR) estimates of exposure with 
intracerebral hemorrhage from the inverse-variance weighted (IVW) and sensitivity 
analysis.
Phenotype IVs (SNPs) OR (95% CI) p
CRP
IVW 42 1.263 (0.935–
1.704)
0.127








MR_Egger 42 1.432 (0.906–
2.266)
0.133




IVW 16 0.879 (0.042–
18.281)
0.933








MR_Egger 16 1.663 (0.004–
746.651)
0.872
MR-PRESSO 16 1.221 (−1.893 to 
4.335)
0.901
CRP, C-reactive protein; IVW, inverse-variance weighted; MR, Mendelian randomization; 
WM, weighted median; PWM, penalized weighted median; OR, odds ratio; 
MR-PRESSO, pleiotropy residual sum and outlier; CI, confidence interval.
TABLE 2 | Heterogeneity tests and MR-Egger intercept of CRP and fibrinogen causally linked to ICH.
Outcome Exposure Intercept pa Cochran’s Q Q_df pb
ICH CRP −0.010 0.480 36.775 40 0.616
ICH Fibrinogen −0.008 0.815 28.028 15 0.045
aValue of p for MR-Egger intercept.
bValue of p for heterogeneity tests by performing inverse-variance weighted method.  
CRP, C-reactive protein; ICH, intracerebral hemorrhage.
Wang et al. Systemic Inflammation in Intracerebral Hemorrhage
Frontiers in Genetics | www.frontiersin.org 4 February 2021 | Volume 12 | Article 608714
that elevated levels of fibrinogen did not exhibit suggestive 
evidence of association with HS (Alvarez-Perez et  al., 2011). 
In line with our results, no significant association between 
fibrinogen and ICH was observed in observational studies 
(Woodward et al., 2005; Welsh et al., 2008; Folsom et al., 2016). 
However, greater plasma fibrinogen concentration was associated 
A B
FIGURE 1 | Forest plots and scatter plots of CRP-associated SNPs potential effects on intracerebral hemorrhage (ICH). Forest plot (A) shows the odds ratio (OR) 
with a horizontal line representing 95% CI for the CRP-associated SNP allele for ICH risk. Scatter plot (B) shows the per-allele association with ICH risk plotted 
against the per-allele association with 1 SD of CRP (vertical and horizontal black lines presenting the 95% CI of OR for each SNP), with the slope of each line 
corresponding to estimated Mendelian randomization (MR) effect per method.
A B
FIGURE 2 | Forest plots and scatter plots of fibrinogen-associated SNPs potential effects on ICH. Forest plot (A) shows the odds ratio (OR) with a horizontal line 
representing 95% CI for the fibrinogen-associated SNP allele for ICH risk. Scatter plot (B) shows the per-allele association with ICH risk plotted against the per-allele 
association with 1 SD of fibrinogen (vertical and horizontal black lines presenting the 95% CI of OR for each SNP), with the slope of each line corresponding to 
estimated Mendelian randomization (MR) effect per method.
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with increased risk of ICH in these prospective studies 
(Sato et  al., 2006; Sturgeon et  al., 2008). These findings should 
be  interpreted cautiously as higher CRP and fibrinogen levels 
may reflect subclinical infection, chronic infectious diseases, 
preexisting disease, and socioeconomic or lifestyle characteristics. 
Besides, these opposite results may be  due to different study 
populations and ethnic groups (Iso et al., 2012; Shi et al., 2016).
The pathogenesis of the associations of CRP and fibrinogen 
with the risk of ICH is unclear. CRP plays a direct role in 
the pathogenesis of atherosclerosis and is upregulated significantly 
in atheromatous plaques, where it may promote low-density 
lipoprotein cholesterol uptake by macrophages (Torzewski et al., 
2000). Moreover, these inconsistent previous results may be due 
to reverse causal bias or confounders from atherosclerosis 
(Libby et  al., 2011) or inflammation (Hartwig et  al., 2017). 
One possible explanation is that the previous finding was a 
false-positive outcome because the effect of confounding was 
not controlled for, whereas in our studies, the genetic variants 
associated with exposure explained a larger proportion of 
variance, showing the true relationship of CRP and fibrinogen 
with ICH. Another possible explanation is that a mass of 
variants resulted in greater pleiotropy potential, which may 
have diluted the association in our analysis.
The major strengths of this study are using data from large-
scale GWAS studies and ISGC collaboration. We  used a 
two-sample MR approach assessing CRP and fibrinogen levels 
in relation to the risk of ICH in European-descent individuals, 
which reduces bias of population stratification. Moreover, in 
terms of the MR analysis, we  performed conventional IVW, 
WM, PWM, MR-PRESSO, and MR-Egger methods to avoid 
reverse causation and to reduce other confounding factors. 
Lastly, there is no strong evidence of pleiotropic effects for the 
genetic instruments, suggesting there was less likelihood of CRP 
and fibrinogen-related SNPs are associated with other phenotypes.
The present study also has some limitations. Interpreting the 
magnitude of estimates for the effect of CRP and fibrinogen on 
ICH risk requires caution. First, stratified analyses or analyses 
adjusted for other covariates were not possible on the account 
of using the available summary statistics datasets. In addition, 
the genetic IVs accounted for approximately 7.0% of the total 
variation in CRP and 3.7% of plasma fibrinogen variation (Sabater-
Lleal et  al., 2013; Ligthart et  al., 2018), which might be  low for 
the use as IVs, and any bias from weak instruments was in 
the direction of the null (Pierce and Burgess, 2013). Nevertheless, 
MR analysis likely reflects lifelong exposure to elevated CRP 
and fibrinogen levels. However, it is possible that only exposure 
in a specific window of time (e.g., early life) affects ICH risk. 
Lastly, we  used a relatively small sample size to explore the 
causal relationship between CRP, fibrinogen, and ICH with the 
power of less than 0.90. Thus, the nonsignificant but still suggestive 
associations between CRP and fibrinogen levels and ICH risk 
should be further validated in future studies with larger independent 
populations and larger datasets offering greater statistical power.
In conclusion, these MR analyses did not find evidence to 
support the causal relationship between CRP and fibrinogen 
with ICH. The results add to the burgeoning evidence that 
refutes the harmful role of CRP and fibrinogen in ICH. Further 
research is required to clarify this finding, using larger samples 
for undertaking “adjusted” MR analyses.
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